Sign in

CIK 0001856725

  • Emerging growth company

Rani Therapeutics Holdings, Inc.

Sign in to watch
Ticker
RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
863114789
Phone
+1 408-457-3700
Business address
47709 FREMONT BLVD, FREMONT, CA, 94538
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale 10% owner sold 5,265,165 shares at $2.01 ($10,582,982)
  13. 4 Open-market buy 10% owner bought 5,265,165 shares at $2.01 ($10,582,982)
  14. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.27 ($22,700)
  15. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.57 ($12,850)
  16. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.05 ($41,000)
  17. 4 Open-market buy Director bought 50,500 shares at $2.03 ($102,495)
  18. 4 Open-market buy Director bought 500 shares at $1.98 ($990)
  19. 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $2.00 ($9,975)
  20. 4 Derivatives Options or other derivatives

Page 4 of 10 · 194 filings